A groundbreaking trial in June 2024 revealed that lenacapavir, a new HIV prevention drug, was 100% effective in protecting over 5,000 girls and women in Uganda and South Africa. This drug, administered via injection every six months, outperformed daily PrEP pills, which require consistent daily intake. Lenacapavir, developed by Gilead, has been approved by the FDA for treating resistant HIV strains but not yet for prevention. However, Gilead has made agreements to produce generic versions for 120 low-income countries. In October, further trials showed lenacapavir to be 96% effective in preventing HIV among 3,200 diverse groups. Despite the availability of effective HIV prevention drugs since 2012, access remains a challenge. The United Nations aims to end AIDS by 2030, with over 1 million new infections annually, highlighting the urgent need for broader access to these innovative treatments.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
